| Shelly Ann Bingham, PC | |
|
750 N 200 W, Provo, UT 84601-1677 | |
| (801) 373-4760 | |
| Not Available |
| Full Name | Shelly Ann Bingham |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 750 N 200 W, Provo, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174798680 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 281194-6009 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Shelly Ann Bingham, PC 750 N 200 W, Provo, UT 84601-1677 Ph: (801) 373-4760 | Shelly Ann Bingham, PC 750 N 200 W, Provo, UT 84601-1677 Ph: (801) 373-4760 |
News Archive
In a new study, researchers show an aerosolized, inhalable form of the drug Ambrisentan could offer a faster-acting treatment option for pulmonary edema, a life-threatening condition in which fluid accumulates in the lungs. Pulmonary edema is a significant risk for anyone spending time at high altitudes, and also affects people with chronic conditions including congestive heart failure and sickle cell anemia.
MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today its record results for the first quarter of 2015.
SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today announced that the Company's dermaPACE device will be the subject of a presentation at Plastic Surgery 2011, the American Society of Plastic Surgeons' National Meeting being held September 23-27 in Denver.
Amgen Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has announced a positive opinion for the marketing authorization of Prolia((TM)) (denosumab) for the treatment of osteoporosis in postmenopausal women at increased risk of fractures, and for the treatment of bone loss associated with hormone ablation in men with prostate cancer at increased risk of fractures.
NPS MedicineWise programs targeting quality use of medicines in cardiovascular management have improved prescribing and cardiovascular disease management in primary care, according to a study published in the Medical Journal of Australia today.
› Verified 5 days ago
Dallas Bean, Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 750 N 200 W Ste 300, Provo, UT 84601 Phone: 801-373-4760 | |
Brenna Garrett, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1300 E Center St, Provo, UT 84606 Phone: 801-344-4400 | |
Mrs. Karen Dee Amsden, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 750 N Freedom Blvd, Provo, UT 84601 Phone: 801-373-4760 | |
Mr. John Paul Lilly, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 286 S 600 E, Suite C, Provo, UT 84606 Phone: 801-377-8232 Fax: 801-377-0930 | |
Frederick Brewer, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 750 N Freedom Blvd, Suite 108, Provo, UT 84601 Phone: 801-373-7394 | |
William Kory Camp, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 1300 E Center St, Provo, UT 84606 Phone: 801-344-4215 | |
Alaina Barrick, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4045 N Canyon Rd, Provo, UT 84604 Phone: 859-582-0032 |